Stonegate Updates Coverage on NZX Limited (NZX) Q4 2024
Dallas, Texas--(Newsfile Corp. - February 24, 2025) - NZX Limited (NZSE: NZX): Stonegate Capital Partners updates their coverage on NZX Limited (NZSE: NZX). NZX reported revenue, adj EBITDA, and adj EPS of $62.9M, $24.7M, and $10.22, respectively. This compares to our estimates of $61.0M, $22.1M, and $7.94. Topline outperformance was due to strong results in all segments. This outperformance was exacerbated by higher GPM than expected in the Wealth Tech segment. To view the full announcement,...
2025-02-24 9:25 AM EST
Stonegate Capital Partners Updates 4Q24 Report on Gladstone Commercial Corp. (GOOD)
Dallas, Texas--(Newsfile Corp. - February 20, 2025) - Gladstone Commercial Corporation.(NASDAQ: GOOD): Stonegate Capital Partners Updates Coverage on Gladstone Commercial Corp. (NASDAQ: GOOD). GOOD reported revenue, FFO per share, and AFFO per share of $37.4M, $0.35, and $0.23, respectively. This compares to our/consensus estimates of $38.6M/$38.0M, $0.34/$0.35, and $0.31/$0.28. Core FFO for the quarter was $0.35 per share, down from $0.38 in 3Q24. This was primarily driven by a settlement...
2025-02-20 9:30 AM EST
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY25 Q3
Dallas, Texas--(Newsfile Corp. - February 19, 2025) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). In the third quarter of 2025, Burcon made significant progress in its strategic initiatives. The Company successfully ramped up commercial production of its canola protein isolate, marking a pivotal milestone in its go-to-market strategy. With over 100 prospective customers evaluating its protein...
2025-02-19 4:26 PM EST
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025
Dallas, Texas--(Newsfile Corp. - February 18, 2025) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). During the second quarter of fiscal year 2025, Incannex Healthcare Inc. reported R&D costs of $1.4M, a decrease from $2.6M in the same period of the previous year. This reduction was primarily due to the completion of the IHL-42X safety and pharmacokinetics clinical trial and the reallocation of resources...
2025-02-18 5:52 PM EST
Stonegate Updates Coverage on EnSilica PLC (ENSI) 1H 2025
Dallas, Texas--(Newsfile Corp. - February 18, 2025) - EnSilica PLC (AIM: ENSI): Stonegate Capital Partners updates their coverage on EnSilica PLC (AIM: ENSI). In 1H25, EnSilica PLC continued to build on its strategic initiatives and market strengths, achieving significant milestones. The Company's strong position and intellectual property in automotive, industrial, healthcare, and satellite connectivity applications for mixed-signal ASICs continue to provide a competitive edge. We believe...
2025-02-18 5:05 PM EST
Expanse (GMGI) Launches Game #55, Adds to U.S. Social Casino-Compatible Offer
Las Vegas, Nevada--(Newsfile Corp. - February 14, 2025) - The U.S. sweepstakes and social casino market is evolving rapidly, and Expanse Studios--part of Golden Matrix Group Inc. (NASDAQ: GMGI)--continues to expand its footprint with its latest release, Candy's Bonanza. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Expanse Studios releases its 55th game, reinforcing its position as a leading B2B iGaming content producer and provider...
2025-02-14 11:14 AM EST
VueReal Appoints Robert Selley as Chief Commercial Officer
Waterloo, Ontario--(Newsfile Corp. - February 11, 2025) - VueReal, a pioneer in MicroSolid Printing technology, today announced the executive appointment of Robert Selley as its new Chief Commercial Officer (CCO). With over 25 years of experience in the semiconductor industry, Mr. Selley brings a wealth of knowledge in driving commercial strategies and fostering innovation. In this newly created role, Mr. Selley will oversee all global sales and business development activities and help drive...
2025-02-11 9:47 AM EST
Golden Matrix (GMGI) Ready for Super Bowl LIX with 900+ AI-Powered Lines & Prop Bets
Las Vegas, Valetta--(Newsfile Corp. - February 9, 2025) - The Super Bowl LVIII is just hours away. Meridianbet, part of Golden Matrix Group (NASDAQ: GMGI), is setting new industry standards, rolling out a record-breaking 880+ unique betting options for the biggest sporting event in the U.S. Meridianbet, part of the GMGI, is also bringing innovation to Super Bowl LVIII with its AI Sports Betting Recommender, an advanced feature that personalizes betting experiences by analyzing player...
2025-02-09 5:07 PM EST
Golden Matrix (GMGI) Integrates with Second U.S. Sweepstakes Operator
Las Vegas, Nevada--(Newsfile Corp. - February 7, 2025) - Expanse Studios, part of Golden Matrix Group Inc. (NASDAQ: GMGI), continues to expand its presence in the U.S. sweepstakes market, successfully integrating with its second major U.S. social casino operator. This new integration brings Expanse Studios' portfolio of premium slots, crash games, and table games to players across 40+ states, including key markets such as California, New York, and Florida. The operator, part of one of the...
2025-02-07 2:02 PM EST
Meridianbet (GMGI) Listed on Oracle's Global Tech Reference Page
Las Vegas, Nevada--(Newsfile Corp. - February 7, 2025) - Meridianbet, the sports betting and iGaming division of Golden Matrix Group (NASDAQ: GMGI) has been featured on Oracle's Global Customer Reference Page--a dedicated platform showcasing the most advanced, high-impact projects implemented with Oracle technology, a global leader in enterprise tech powering the world's top businesses. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways:...
2025-02-07 8:28 AM EST
InFlectis BioScience Announces Promising Results for IFB-088 in a Phase 2a Clinical Study in Bulbar-Onset ALS Patients
Nantes, France--(Newsfile Corp. - February 6, 2025) - InFlectis BioScience SAS, a drug discovery company pioneering development of therapeutics harnessing the Integrated Stress Response (ISR) for a spectrum of neurological diseases, today announced the successful completion of its P288ALS TRIAL study (NCT05508074). This study was designed as a randomized, double-blind, placebo-controlled, parallel-group phase 2a trial comparing its drug candidate IFB-088 (25 mg BID) plus riluzole with placebo...
2025-02-06 7:08 AM EST
Sethera Therapeutics Appoints Biotech Pioneer Dr. Robert Langer to Head and Chair the Scientific Advisory Board and Brigadier General Larry Lunt to Board of Directors
Salt Lake City, Utah--(Newsfile Corp. - February 5, 2025) - Sethera Therapeutics announced the appointment of Dr. Robert Langer, a world-renowned scientist, entrepreneur, and co-founder of Moderna, to Head and Chair its Scientific Advisory Board. The company also welcomed Brigadier General Larry V. Lunt, USAF (Ret.), a distinguished leader with decades of strategic expertise, to its Board of Directors. To view the full announcement, including downloadable images, bios, and more, click here....
2025-02-05 9:08 AM EST
Stonegate Capital Partners Updates Coverage on Alliance Resource Partners, L.P. (ARLP) 2024 Q4
Dallas Texas--(Newsfile Corp. - February 4, 2025) - Alliance Resource Partners, L.P. (NASDAQ: ARLP): Stonegate Capital Partners updates coverage on Alliance Resource Partners, L.P. ARLP reported a challenging 4Q24, impacted by lower coal sales pricing and higher operating expenses. Total revenues for the quarter decreased by 5.6% year-over-year to $590.1M, primarily due to a 2.3% decline in coal sales volumes. Net income for the quarter was down to $16.3M compared to $115.4M in 4Q23,...
2025-02-04 9:43 AM EST
Stonegate Updates Coverage on Isabella Bank Corporation (ISBA) 2024 Q4
Dallas, Texas--(Newsfile Corp. - February 3, 2025) - Isabella Bank Corporation (OTCQX: ISBA): Stonegate Capital Partners updates their coverage on Isabella Bank Corporation (OTCQX: ISBA). Isabella Bank reported another solid quarter with steady financial performance during 4Q24. Total loans remained steady at $1.42 B at the end 4Q24 due to increases in residential and commercial loans, offset by a decrease in advances to mortgage brokers. Wealth Management fees increased by ~14% y/y,...
2025-02-03 11:08 AM EST
Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)
Dallas, Texas--(Newsfile Corp. - January 30, 2025) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners initiates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG). Alpha Cognition Inc. reported significant progress in 2024 so far, marked by key financial and corporate milestones. Alpha Cognition received approval for its flagship Alzheimer's therapy ZUNVEYL (benzgalantamine), successfully raised $4.5M in financing, and completed the necessary preparations for listing on the...
2025-01-30 11:05 AM EST
VueReal Secures Access to USD $40.5 Million Investment to Scale Production and Expand its Global Ecosystem
Waterloo, Ontario--(Newsfile Corp. - January 30, 2025) - VueReal, a pioneer in MicroSolid Printing, today announced it has secured access to USD $40.5 million in Series C funding. The round was led by Export Development Canada (EDC) and included participation from existing VueReal investors, including Cycle Capital, BDC Capital's Cleantech Practice, and TDK Ventures. This significant investment will enable VueReal to scale its production capabilities and enhance its ecosystem to support...
2025-01-30 8:42 AM EST
Stonegate Updates Coverage on Third Coast Bancshares, Inc. (TCBX) Q4 2024
Dallas, Texas--(Newsfile Corp. - January 27, 2025) - Third Coast Bancshares, Inc. (NASDAQ: TCBX): Stonegate Capital Partners updates their coverage on Third Coast Bancshares, Inc. For 4Q24, Third Coast reported net income of $13.7M, up from $12.8M in 3Q24. This was equal to a basic and diluted EPS of $0.92 and $0.79, respectively. The Q/Q growth was primarily attributed to higher net interest income, driven by loan growth and increased investments in federal funds sold and interest-bearing...
2025-01-27 9:44 AM EST
GMGI's Expanse Doubles U.S. Sweepstakes Game Lineup
Las Vegas, Nevada--(Newsfile Corp. - January 17, 2025) - Expanse Studios, the in-house development division of Golden Matrix Group Inc. (NASDAQ: GMGI), continues to strengthen its position at the US. In just a few weeks since entering the U.S. sweepstakes casino market in late 2024, Expanse Studios has doubled the number of games it supplies, underscoring its rapid growth and ability to deliver high-quality gaming solutions. To view the full announcement, including downloadable images, bios,...
2025-01-17 9:04 AM EST
Wendt Partners Continues to Lead as a Top Global HubSpot Elite Partner in Q4 2024
New York, New York--(Newsfile Corp. - January 13, 2025) - Wendt Partners, a HubSpot Elite Solutions Partner headquartered in New York, announced today that the firm successfully concluded Q4 2024 with a host of major client wins as well as significant staff promotions and continued execution of the firm's global growth strategy. Wendt Partners continued to secure an average of ten or more new logos monthly, with some of the quarter's key new and continuing accounts including these world-class...
2025-01-13 10:45 AM EST
ADVA Biotechnology and Cellipont Bioservices Showcase Accelerated Transition from R&D to GMP at Advanced Therapies Week 2025
Woodlands, Texas--(Newsfile Corp. - January 13, 2025) - ADVA Biotechnology and Cellipont Bioservices are proud to announce their participation at Advanced Therapies Week 2025, taking place in Dallas, Texas, from January 20-23, 2025. Together, they will present a showcase study highlighting how their collaboration successfully transitioned a CAR-T process from a complex manual workflow to a streamlined, automated solution, achieving results with enhanced process control and consistency. To...
2025-01-13 8:48 AM EST